MedTrace Logo

Precision Approach to PPI Therapy in Gastroesophageal Reflux Disease

NCT03619811 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2021-09-20

Study results available
· View outcomes & findings →

Summary

This study plans to learn more about reflux associated laryngeal symptoms, and more efficient ways to diagnose and treat this condition.

Conditions

  • Gastroesophageal Reflux
  • Laryngopharyngeal Reflux

Interventions

DIAGNOSTIC_TEST

Reflux Band® Upper Esophageal Sphincter (UES) Assist Device

UES augmentation via the UES assist device is effective in true Reflux associated laryngeal symptoms. In our first pilot trial with the UES assist device, patients had significant symptom reduction following 2 weeks of UES assist device use. Based on our preliminary work, we theorize that the UES assist device is effective in Reflux associated laryngeal symptoms.

Sponsors & Collaborators

Principal Investigators

  • Rena Yadlapati, M.D. · University of California, San Diego

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-13
Primary Completion
2021-06-30
Completion
2021-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03619811 on ClinicalTrials.gov